Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    17962510 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Salvage reinduction chemotherapy including Gemtuzumab ozogamicin, Idarubicin and Cytarabine and Vorinostat
2 Active, not recruiting Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Azacitidine;   Drug: Vorinostat

Study has passed its completion date and status has not been verified in more than two years.